Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Akumin Inc.

Akumin Inc. (AKU) Stock Overview

Explore Akumin Inc.’s financial performance, market position, analyst ratings, and future outlook.

AKU●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.29
$0.06(17.87%)
U.S. Market opens in 13h 56m

Akumin Inc. (AKU)

Meyka AI Score

Z

Key Financials

Market Cap26.3M
P/E Ratio-0.17
EPS (TTM)$-2.19
ROE-5.32%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

AKU Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Akumin Inc. (NASDAQ: AKU) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Akumin Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AKU on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Akumin Inc.'s NASDAQ-traded stock include a P/E ratio of -0.17 and a market capitalization of 26.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AKU on the NASDAQ.

Price Performance (NASDAQ: AKU)

1-Day Change
N/A
5-Day Change
-9.78%
1-Month Change
-17.87%
3-Month Change
76.04%
6-Month Change
-29.59%
Year-to-Date (YTD) Change
-60.25%
1-Year Change
-72.24%
3-Year Change
-91.36%
5-Year Change
-90.38%
All-Time (Max) Change
-90.38%

Contact Information

https://www.akumin.com
954 577 6000
8300 West Sunrise Boulevard, Plantation, FL, 33322

Company Facts

17,370 Employees
IPO DateSep 3, 2020
CountryUS

Frequently Asked Questions